Digital health for emotional and self-management support of caregivers of children receiving growth hormone treatment: a feasibility study protocol.

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as an observational study.

Accordingly, this study aims to examine the usability of a mobile DH solution and the feasibility of a DH intervention designed to promote emotional and mental wellbeing of caregivers of children undergoing GHt.

Why It Was Studied

Caregivers of children undergoing growth hormone treatment often face stress and stigma.

Here, mindfulness and parenting-based programs have been developed to support the mental wellbeing of caregivers and, in turn, promote richer interactions with the children.

Who Took Part

PubMed indexes the participants as children.

This is a prospective mixed-methods (qualitative-quantitative) exploratory study composed of two sub-studies, including caregivers of children undergoing GHt.

Usability and engagement will also be assessed during and at the end of the study.

What Was Measured

The subject headings attached to it are Caregivers, Feasibility Studies, Growth Hormone, Quality of Life and Self-Management.

The authors tagged it with the keywords Emotional wellbeing, Family-centered approach, Pediatric endocrinology and mHealth.

What This Means in Plain Language

This is an observational study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2022 (BMC medical informatics and decision making), a journal based in England.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.